161 related articles for article (PubMed ID: 23328228)
21. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C
EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166
[TBL] [Abstract][Full Text] [Related]
22. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors.
Block A; Chen SH; Kosai K; Finegold M; Woo SL
Pancreas; 1997 Jul; 15(1):25-34. PubMed ID: 9211489
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated double suicide gene selectively kills gastric cancer cells.
Luo XR; Li JS; Niu Y; Miao L
Asian Pac J Cancer Prev; 2012; 13(3):781-4. PubMed ID: 22631647
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene.
Aoki K; Yoshida T; Matsumoto N; Ide H; Hosokawa K; Sugimura T; Terada M
Hum Gene Ther; 1997 Jun; 8(9):1105-13. PubMed ID: 9189768
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
Kojima Y; Honda K; Hamada H; Kobayashi N
J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
[TBL] [Abstract][Full Text] [Related]
26. Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer.
Ge Y; Lei W; Ma Y; Wang Y; Wei B; Chen X; Ru G; He X; Mou X; Wang S
Mol Med Rep; 2017 Jun; 15(6):3521-3528. PubMed ID: 28440486
[TBL] [Abstract][Full Text] [Related]
27. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
28. A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.
Liu SH; Yu J; Sanchez R; Liu X; Heidt D; Willey J; Nemunaitis J; Brunicardi FC
Cancer Lett; 2018 Apr; 418():75-83. PubMed ID: 29309817
[TBL] [Abstract][Full Text] [Related]
29. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
[TBL] [Abstract][Full Text] [Related]
30. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
31. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
32. Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo.
Cascante A; Huch M; Rodríguez LG; González JR; Costantini L; Fillat C
Hum Gene Ther; 2005 Dec; 16(12):1377-88. PubMed ID: 16390269
[TBL] [Abstract][Full Text] [Related]
33. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
[TBL] [Abstract][Full Text] [Related]
34. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses.
Komarova S; Kawakami Y; Stoff-Khalili MA; Curiel DT; Pereboeva L
Mol Cancer Ther; 2006 Mar; 5(3):755-66. PubMed ID: 16546991
[TBL] [Abstract][Full Text] [Related]
36. The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.
Cherubini G; Kallin C; Mozetic A; Hammaren-Busch K; Müller H; Lemoine NR; Halldén G
Gene Ther; 2011 Dec; 18(12):1157-65. PubMed ID: 21975464
[TBL] [Abstract][Full Text] [Related]
37. Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells.
Bofill-De Ros X; Villanueva E; Fillat C
Oncotarget; 2015 Mar; 6(8):6179-90. PubMed ID: 25714032
[TBL] [Abstract][Full Text] [Related]
38. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
Yamamoto Y; Hiraoka N; Goto N; Rin Y; Miura K; Narumi K; Uchida H; Tagawa M; Aoki K
J Control Release; 2014 Oct; 192():284-93. PubMed ID: 25108153
[TBL] [Abstract][Full Text] [Related]
39. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
